Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$319K Buy
9,726
+123
+1% +$4.14K 0.02% 960
2015
Q2
$356K Sell
9,603
-138
-1% -$5.02K 0.02% 951
2015
Q1
$341K Buy
9,741
+1,122
+13% +$39.6K 0.02% 959
2014
Q4
$328K Buy
8,619
+459
+6% +$16.8K 0.02% 954
2014
Q3
$290K Buy
8,160
+680
+9% +$25.3K 0.02% 955
2014
Q2
$292K Buy
7,480
+81
+1% +$3.03K 0.02% 959
2014
Q1
$269K Buy
7,399
+16
+0.2% +$583 0.02% 953
2013
Q4
$255K Sell
7,383
-1,193
-14% -$38.4K 0.02% 952
2013
Q3
$240K Buy
8,576
+303
+4% +$8.08K 0.02% 865
2013
Q2
$223K Buy
+8,273
New +$228K 0.02% 816

Other funds holding XYL

OFI Advisors's XYL Position: Q3 2015 in Review

OFI Advisors increased its Xylem (XYL) stake by 1.3% in Q3 2015, buying an estimated $4.14K and bringing the position to 9,726 shares worth $319K. The position accounts for 0.02% of the portfolio, ranked #960.

OFI Advisors first reported a position in XYL in Q2 2013 and has held it in 10 quarters since. The position peaked at $356K in Q2 2015. 419 funds tracked by Wall St. Rank hold XYL as of Q3 2015.

  • OFI Advisors held 9,726 shares of Xylem worth $319K as of Q3 2015.
  • OFI Advisors bought 123 Xylem shares in Q3 2015, an estimated $4.14K.
  • Xylem made up 0.02% of OFI Advisors's portfolio in Q3 2015, its #960 holding.
  • OFI Advisors first reported a position in Xylem in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Xylem position peaked at $356K in Q2 2015.
  • 419 funds tracked by Wall St. Rank held Xylem as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.